Polyclonal antibodies market is anticipated to grow at a significant CAGR during the forecast period. The growing use of polyclonal antibodies in various research applications primarily drive market growth. Polyclonal antibodies are composed of a mixture of antibodies that represent the natural immune response to an antigen and thus are highly utilized in general research applications. Adding to this, the globally rising incidence of cancer led by the significant rise in awareness campaigns and research funding on cancer is expected to boost their further use in the disease treatment. For instance, in 2018, the UK Government funded around $300 million for cancer treatment.
Besides cancer, the growing global incidence of infectious diseases including the Ebola virus, particularly in under-developed countries, is anticipated to drive the market growth during the forecast period. For instance, as per the World Health Organization (WHO) in February 2020, the outbreak of the Ebola virus in West Africa was the largest outbreak during 2014-2016 and it still continues in various countries.
Some key players operating in the market include Agilent Technologies, Inc., Abcam plc, Thermo Fisher Scientific Inc, and Merck KGaA, among others. The market players are eyeing to strengthen their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, investment in research and development, and so on. For instance, in August 2018, SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, announced that its anti-Ebola immunotherapy, SAB-139, offers100% protection against a lethal dose of the Ebola virus in an animal study published in The Journal of Infectious Diseases. The study was conducted by the National Interagency Confederation for Biological Research in collaboration with the US Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Naval Medical Research Center (NMRC).
To Request a Sample of our Report on Polyclonal Antibodies Market: https://www.omrglobal.com/request-sample/polyclonal-antibodies-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Agilent Technologies, Inc., Abcam plc, Thermo Fisher Scientific Inc, and Merck KGaA, among others.
Polyclonal Antibodies Market by Segment
By Type
- Primary Antibody
- Secondary Antibody
By Application
- Academic Research
- Commercial Application
A full Report of Polyclonal Antibodies Market is Available @ https://www.omrglobal.com/industry-reports/polyclonal-antibodies-market
Polyclonal Antibodies Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/polyclonal-antibodies-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
